ERBB2 and breast cancer: In accordance with the tumor-agnostic philosophy, however, mutated RET variants were also found in neoplasms of breast tissue, widening the diagnostic and treatment repertoire for HER2-negative and -positive breast cancers which are resistant to current traditional treatment [77,78].